As some states reopen businesses and more Americans will resume visiting their doctors, clinicians are concerned about a second wave of COVID-2 infections, according to a survey of clinical leaders.

Some major healthcare companies, including DaVita, Cigna, Encompass, CVS Health and Walmart, are sending back federal aid funding they received that was intended to help hospitals and healthcare providers during the COVID-19 pandemic.

The U.S. hit a new milestone in the COVID-19 pandemic, surpassing 100,000 deaths caused by the virus––more than anywhere else on Earth.

The World Health Organization has suspended the trial of the controversial drug hydroxychloroquine due to safety concerns.

Testing the combined residents of the nation’s assisted living facilities and nursing homes would cost a whopping $672 million for just one round of testing.

Cigna, one of the nation’s largest health insurance companies, has expanded its virtual support services for mental and emotional health by adding Talkspace to its behavioral provider network.

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

Dick Daniels, chief information officer and vice president at Kaiser Permanente, announced his decision to retire mid-June.

More than 1,750 standalone Medicare Part D prescription drug plans and MA plans have applied to offer insulin at a maximum $35 copay for a month’s supply of the drug for the 2021 plan year, CMS announced.

The healthcare sector has seen an influx of funding from private equity groups over the last several years, aiding in the contraction of the industry. But has the influence of cash been beneficial for healthcare?

CMS has finalized a rule to implement a series of proposals issued earlier this year impacting Medicare Advantage plans and Medicare Part D plan sponsors. The rules were rushed into effect to get them out before the contract year 2021 bid deadline in June.

Technology companies Apple and Google have teamed up to build an element of contact tracing to aid in the COVID-19 response.